After nephrectomy, how long should Jardiance (empagliflozin) be held before restarting?

Jardiance Perioperative Management After Nephrectomy

Jardiance (empagliflozin) should be held for at least 2 days before nephrectomy and restarted only after the patient is eating and drinking normally with documented stable renal function, typically 48-72 hours postoperatively or longer depending on renal recovery.

Preoperative Holding Period

The most recent multidisciplinary consensus guideline 1 recommends omitting SGLT2 inhibitors the day before and the day of the procedure. This translates to a minimum 36-48 hour hold period before surgery. The KDIGO 2022 guidelines 2 support withholding SGLT2 inhibitors "during times of prolonged fasting, surgery, or critical medical illness" due to ketoacidosis risk.

For major surgery requiring hospitalization (which nephrectomy qualifies as), the consensus recommends withholding at least 2 days in advance 1. The 2025 ADA Standards 3 specifically state SGLT2 inhibitors should be discontinued 3-4 days before surgery, representing the most conservative and recent guidance.

Critical Perioperative Considerations

Ketoacidosis Risk

The primary concern is euglycemic diabetic ketoacidosis, which can occur even with normal blood glucose levels 4, 2. This risk persists even when SGLT2 inhibitors are held for >72 hours 1, making the perioperative period particularly high-risk after nephrectomy due to:

• Acute kidney injury from surgery
• Prolonged fasting periods
• Volume depletion
• Surgical stress and catabolism

Renal Function Impact

Nephrectomy creates an acute kidney disease state where the remaining kidney must compensate. SGLT2 inhibitors cause a reversible decrease in eGFR through hemodynamic effects 2, which is normally tolerated but becomes problematic when baseline renal function is acutely compromised.

Postoperative Restart Criteria

Do not restart Jardiance until ALL of the following are met:

1. Patient is eating and drinking normally (not just tolerating sips)
2. Minimum 48-72 hours post-surgery for major procedures 5
3. Documented stable renal function - verify creatinine is stable or improving, not rising
4. Adequate volume status - patient is euvolemic without ongoing fluid shifts
5. Blood ketones <0.6 mmol/L if measured (recommended for inpatients) 1
6. No ongoing complications requiring continued fasting or critical care

For nephrectomy specifically, given the permanent reduction in renal mass, wait at least 72 hours and until you have documented the new baseline eGFR before restarting. The FDA label 6 notes that empagliflozin efficacy decreases with declining renal function, and the drug should not be initiated if eGFR <20 mL/min/1.73 m².

Practical Algorithm

Preoperative:

• Stop Jardiance 3-4 days before scheduled nephrectomy 3
• Provide written sick-day rules to patient 1
• Adjust other diabetes medications as needed

Postoperative Day 1-2:

• Monitor blood glucose closely
• Check ketones if available (especially if glucose >250 mg/dL or patient symptomatic)
• Assess volume status and renal function daily
• Continue holding Jardiance

Postoperative Day 3+:

• Verify patient tolerating regular diet
• Check creatinine/eGFR to establish new baseline
• Ensure ketones <0.6 mmol/L if measured
• If all criteria met, may restart at previous dose

If eGFR 20-45 mL/min/1.73 m²:

• Jardiance can be continued for cardiovascular/renal benefits 2
• Glycemic efficacy will be reduced 6
• Monitor closely for volume depletion

If eGFR <20 mL/min/1.73 m²:

• Do not restart Jardiance 4, 2
• Consider alternative glucose-lowering agents

Common Pitfalls to Avoid

1. Restarting too early - The 24-48 hour window mentioned for day-stay procedures 1 does NOT apply to major surgery like nephrectomy
2. Ignoring new renal baseline - Post-nephrectomy eGFR will be permanently lower; reassess appropriateness of SGLT2 inhibitor
3. Missing euglycemic DKA - Normal glucose does not exclude ketoacidosis; maintain high suspicion if patient has nausea, vomiting, or abdominal pain
4. Inadequate hydration - Ensure patient is truly euvolemic before restart, as SGLT2 inhibitors cause osmotic diuresis
5. Forgetting sick-day rules - Provide discharge instructions to hold Jardiance during future illness or dehydration 1

The evidence consistently prioritizes safety over early resumption of SGLT2 inhibitors in the perioperative period, with the understanding that short-term discontinuation poses minimal risk compared to the potentially fatal complication of perioperative ketoacidosis.